We assessed whether weight reduction is an effective intervention for the management of lower urinary tract symptoms (LUTS) and investigated the relationship between obesity and LUTS. Materials and Methods: This was a prospective randomized controlled trial that enrolled obese men older than 50 years with LUTS. The study period was 52 weeks. All patients received standardized alpha-adrenergic blocker therapy for the treatment of benign prostatic hyperplasia (BPH) during the run-in period. Patients were randomized to receive either a standardized prerecorded video program on the general principle of weight reduction or a comprehensive weight reduction program. Patients were assessed at different time points with symptom assessment, uroflowmetry, transrectal ultrasound, and metabolic assessment. Results: Sixty-five patients were allocated to each study arm. After the study period, no significant difference in weight reduction was found between the two arms. When the pre-and postintervention parameters were compared, none were statistically different between the 2 arms, namely nocturia, International Prostate Symptom Score, quality of life assessment, and uroflowmetry parameters. When the whole study population was taken as a single cohort, these parameters were also not significantly different between the group with a body mass index of 25 to <30 kg/m 2 and the group with a BMI of 30 to 35 kg/m 2 .
INTRODUCTION
Lower urinary tract symptoms (LUTS) are common among middle-aged to elderly men [1] . It is increasingly recognized that the etiology of LUTS extends well beyond Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: A randomized controlled trial
Weight reduction in obese men with LUTS
gesting that obese men are more likely to have LUTS [3, 4] , weight reduction could be one such intervention. Body size and composition have long been hypothesized to influence the risk of prostate hyperplasia [5] . While some data have suggested that weight gain worsens LUTS, few data are available to address whether the reverse is true, i.e., if weight loss can improve LUTS. Furthermore, the postulated relationship between obesity and LUTS remains controversial. Contradictory evidence about this relationship is present in the literature [6] . With this background, we conducted a prospective randomized controlled trial to investigate whether weight reduction would be an effective intervention for LUTS and assessed the relationship between obesity and LUTS among patients with BPH.
MATERIALS AND METHODS
This was a prospective randomized controlled trial. The study was approved by the local ethics and research commi ttee. Written informed consent was given by all partici pants before entering the study. Obese men older than 50 years who attended our urology clinic for LUTS were enrolled. A standard investigation protocol that included a general clinical evaluation with digital rectal examination, transrectal ultrasound (TRUS), blood tests, prostate-spe ci fic antigen (PSA) measurement, uroflowmetry, and assessment of International Prostate Symptom Score (IPSS) and quality of life (QoL) score was performed during enrol ment. Baseline medical history was documented. Details of the inclusion and exclusion criteria are listed in Table 1 .
The study period was 52 weeks. Before the study, patients had been using different alpha blockers for relief of LUTS. Standardized alpha-adrenergic blocker therapy (tamsulosin 0.4 mg oral controlled absorption system) for the medical treatment of BPH/LUTS was given to all patients during the run-in period. Subjects were reassessed at 4 weeks after the run-in period for assessment of baseline parameters. After these assessments, patients we re randomly assigned to receive either a standardized prerecorded video program on the general principle of weight reduction or a comprehensive weight reduction program.
The comprehensive weight reduction program included 3 aspects, namely, an integrated assessment, a weight reduc tion protocol, and medical nutrition therapy. The integrated assessment included assessment of dietary and acti vity patterns together with appropriate coun seling. Then a weight reduction protocol was devised and supervised by a registered physiotherapist with an American College of Sports Medicine exercise specialist background. The pro tocol consisted of an initial stage, an improvement stage, and a maintenance stage. Concerning the medical nutrition thera py, it was formulated by dietitians to address individual needs for weight reduction.
After randomization, patients were assessed at different time points over the course of 48 weeks with symptom assess ment, EuroQol visual analogue scale (EQ VAS), uro flowmetry, TRUS, and metabolic assessment. The EQ VAS is a visual scale from 0 to 100 for a patient's subjective assess ment of his or her own health state. The higher the score, the better the patient perceives his health state. The follow-up protocol of the study is illustrated in Fig. 1 .
With the aim of assessing the effect of a compre hensive wei ght reduction program on the severity of LUTS, the pri mary end point was a change in IPSS at the end of the trial compared with baseline. Secondary end points in clu ded change in uroflowmetry parameters, change in noc tu ria episodes, and change in prostate volume.
On the basis of our center's database of more than 1,000 patients with LUTS, the mean total IPSS for patients with moderate to severe symptoms is 19 with a standard deviation of 7. A sample size of 65 in each group would have 80% power to detect a 4-point difference in means, with a 0.05 two-sided significance level and a loss to follow-up rate of 30%.
Descriptive statistics were used to characterize the demo- 
RESULTS
A total of 180 patients were assessed for eligibility, 50 patients were excluded for various reasons, and in the end 130 patients were randomly assigned into the two study arms (Fig. 2) . Sixty-five patients were allocated to general weight reduction advice and 65 patients to a comprehensive weight reduction program. In the end, 117 pa tients completed the study. Patient characteristics are listed in Table 2 . There were no significant differences in baseline characteristics between patients in the control arm and those in the active arm.
After the 48-week study period, we noted changes in BMI of -0.4±0.9 kg/m 2 and -0.4±0.8 kg/m 2 in the control arm and the active arm, respectively. The differences between the pre-and postintervention parameters were compared between these two groups, namely, nocturia episodes, total IPSS, IPSS irritative score subset (sum of score of IPSS questions 2, 4, and 7), and EQ VAS. None of these parameters was significantly different between the control and active arms (Table 3) . In view of these negative results, we looked at the whole study population as a single cohort of obese men with LUTS and tried to identify whether there was a relationship between obesity and LUTS. Subjects were categorized into two groups according to their baseline BMI, (Table 2 ).
When we looked at the baseline characteristics of these two groups, we did not notice any significant differences in terms of nocturia episodes, total IPSS, IPSS irritative score subset, IPSS QoL score, EQ VAS, or uroflowmetry parameters. As for prostate size, the group with a higher BMI had a relatively smaller prostate than did the group with a lower BMI (40.1±15.3 mL vs. 56.8±28.4 mL, respectively, p=0.03). We further identified all subjects who had lost weight during the study period, and categorized this group of patients into four quartiles according to the percentage of weight reduction (Table 4) . When we compared LUTS parameters and total IPSS across these four groups, we did not find any statistically significant differences.
DISCUSSION
A number of studies have been carried out to address the relationship between obesity and LUTS, and these have produced mixed results. Kristal et al. [7] reported that each 0.05 increase in waist-to-hip ratio (a measure of abdominal obesity) is associated with a 10% increased risk of IPSS>14 (p<0.003) and IPSS>20 (p<0.02). A similar positive correlation was also observed by Parsons et al. [4] and Mondul et al. [8] . To account for such observations, some have hypothesized that obesity may be linked to increased sympathetic nervous system activity, leading to increased irritative LUTS from smooth muscle contraction [9] . In addition, obese men have an increased estrogento-testosterone ratio, which may play a role in prostatic tissue hyperplasia.
However, such a relationship was not demonstrated in our study. In our whole cohort of obese male subjects, there was no significant difference in LUTS between the group with BMI of 25 to <30 kg/m 2 and the group with BMI of 30-35 kg/m 2 . Such absence of association between obesity and LUTS was also echoed in the studies by Kok et al. [10] and Wong et al. [11] . These contradictory results concerning obesity and LUTS could be in part due to the different degree of obesity in different studies. Mondul et al. [8] . Without a significant difference in BMI, a subtle relationship between obesity and LUTS might fail to be demonstrated in Asian-population-based studies, including our current study. However, it is worthwhile to note that in our cohort, although over weight and obese patients had a similar IPSS, obese patients actually had a smaller mean prostate size (40.1±15.3 mL vs. 56.8±28.4 mL, respectively). This might present a clue to the subtle relationship between obesity and LUTS.
In fact, the degree of weight change with respect to LUTS development was also discussed by St Sauver et al. [6] in their retrospective review of The Olmsted County Study of Urinary Symptoms and Health Status among Men (OCS) and the Flint Men's Health Study. St Sauver et al. [6] reported that modest weight loss and weight gain were not significantly associated with changes in the American Urological Association Symptom Index score. Together with our study's findings, the data seem to suggest that although we cannot completely rule out the association between obesity and LUTS at the moment, a significant weight change or a significant degree of obesity might be needed to demonstrate such an association. The limitation of this study lies in both patient recruitment and patient compliance. Most of our patients belonged to the overweight group (BMI 25 to <30 kg/ m 2 ) and a very small proportion of the subjects belonged to the obese group (BMI 30-35 kg/m 2 ) ( Table 2 ). This distribution might have masked the subtle difference in LUTS parameters between these two BMI groups. In our study, we failed to produce a statistically significant difference in the degree of weight reduction between the control arm and the active arm. Furthermore, there was no statistically significant BMI difference before and after the study period in either group. These findings reflected that even if weight reduction is an effective means of improving LUTS, having patients adhere to a weight loss program is a great challenge. Most trials, employing various therapeutic modalities, are plagued by subsequent weight regain. A systematic review of weight maintenance after lifestyle interventions found that approximately half of the weight lost is regained within 1 year of treat ment cessation [13] . Even within weight loss trials of continual intervention, weight regain is prominent [14] . In our study, the comprehensive weight reduction program provided continuous support to our patients throughout the study period over a relatively long interval. After the initial 6 months, patients were reassessed every 12 weeks. This follow-up interval might have contributed to the low rate of success in weight reduction. To improve the success rate of a weight reduction program, more innovative me asures might be needed in the future. Recently, su ccess was reported in a trial in the setting of Scottish pro fessional f ootball clubs, in which 747 male f ootball fans were recruited in a weight loss program delivered by community coaching staff [15] . This kind of protocol, which is gendersensitized in context, content, and style of delivery, could be our future reference.
CONCLUSIONS
An association between obesity, weight loss, and LUTS was not demonstrated in our study. This could have been due to the less marked weight difference and weight loss in our cohort. Although weight reduction might be an effective measure to improve LUTS, the implementation of a successful weight reduction program remains a challenge.
